These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 32586305)
41. Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia. Morishita F; Yadav RP; Eang MT; Saint S; Nishikiori N PLoS One; 2016; 11(9):e0162796. PubMed ID: 27611908 [TBL] [Abstract][Full Text] [Related]
42. A comparative study of catastrophic health expenditure in Zhejiang and Qinghai province, China. Zhen X; Zhang H; Hu X; Gu S; Li Y; Gu Y; Huang M; Sun X; Wei J; Dong H BMC Health Serv Res; 2018 Nov; 18(1):844. PubMed ID: 30413169 [TBL] [Abstract][Full Text] [Related]
43. Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China. Pan Y; Chen S; Chen M; Zhang P; Long Q; Xiang L; Lucas H Infect Dis Poverty; 2016 Jan; 5():7. PubMed ID: 26812914 [TBL] [Abstract][Full Text] [Related]
44. Catastrophic health expenditures of households living with pediatric leukemia in China. Sui M; Zeng X; Tan WJ; Tao S; Liu R; Liu B; Ma W; Huang W; Yu H Cancer Med; 2020 Sep; 9(18):6802-6812. PubMed ID: 32697427 [TBL] [Abstract][Full Text] [Related]
45. The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal. Gurung SC; Dixit K; Rai B; Caws M; Paudel PR; Dhital R; Acharya S; Budhathoki G; Malla D; Levy JW; van Rest J; Lönnroth K; Viney K; Ramsay A; Wingfield T; Basnyat B; Thapa A; Squire B; Wang D; Mishra G; Shah K; Shrestha A; de Siqueira-Filha NT Infect Dis Poverty; 2019 Dec; 8(1):99. PubMed ID: 31791412 [TBL] [Abstract][Full Text] [Related]
46. Assessment of Household Catastrophic Total Cost of Tuberculosis and Its Determinants in Cairo: Prospective Cohort Study. Ellaban MM; Basyoni NI; Boulos DNK; Rady M; Gadallah M Tuberc Respir Dis (Seoul); 2022 Apr; 85(2):165-174. PubMed ID: 34814238 [TBL] [Abstract][Full Text] [Related]
47. Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: Do Indian households face distress health financing? Kastor A; Mohanty SK PLoS One; 2018; 13(5):e0196106. PubMed ID: 29746481 [TBL] [Abstract][Full Text] [Related]
48. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences. Adhikari SR; Maskay NM; Sharma BP Health Policy Plan; 2009 Mar; 24(2):129-39. PubMed ID: 19181674 [TBL] [Abstract][Full Text] [Related]
49. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis. Akalu TY; Clements ACA; Wolde HF; Alene KA Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144 [TBL] [Abstract][Full Text] [Related]
50. [Study on the direct economic burden and relevant influencing factors of 233 multidrug/rifampicin-resistant pulmonary tuberculosis patients in Jiangsu Province]. Ding H; Lu P; Ding XY; Li ZQ; Zhu LM; Liu Q Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Sep; 45(9):1251-1257. PubMed ID: 39307699 [No Abstract] [Full Text] [Related]
51. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634 [TBL] [Abstract][Full Text] [Related]
53. Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India. Mullerpattan JB; Udwadia ZZ; Banka RA; Ganatra SR; Udwadia ZF Indian J Tuberc; 2019 Jan; 66(1):87-91. PubMed ID: 30797290 [TBL] [Abstract][Full Text] [Related]
54. Changes in economic status of households associated with catastrophic health expenditures for cancer in South Korea. Choi JW; Cho KH; Choi Y; Han KT; Kwon JA; Park EC Asian Pac J Cancer Prev; 2014; 15(6):2713-7. PubMed ID: 24761890 [TBL] [Abstract][Full Text] [Related]
55. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India. Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969 [TBL] [Abstract][Full Text] [Related]
56. Beyond pills and tests: addressing the social determinants of tuberculosis. Wingfield T; Tovar MA; Huff D; Boccia D; Saunders MJ; Datta S; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans C Clin Med (Lond); 2016 Dec; 16(Suppl 6):s79-s91. PubMed ID: 27956446 [TBL] [Abstract][Full Text] [Related]
57. Catastrophic health expenditure: A comparative analysis of smoking and non-smoking households in China. Zhong Z; Wei H; Yang L; Yao T; Mao Z; Sun Q PLoS One; 2020; 15(5):e0233749. PubMed ID: 32469973 [TBL] [Abstract][Full Text] [Related]
58. Decomposing inequality in catastrophic health expenditure for self-reported hypertension household in Urban Shaanxi, China from 2008 to 2013: two waves' cross-sectional study. Si Y; Zhou Z; Su M; Wang X; Lan X; Wang D; Gong S; Xiao X; Shen C; Ren Y; Zhao D; Hong Z; Bian Y; Chen X BMJ Open; 2019 May; 9(5):e023033. PubMed ID: 31076467 [TBL] [Abstract][Full Text] [Related]
59. Assessing the influencing factors of out-of-pocket costs on tuberculosis in Sichuan Province: a cross-sectional study. Xia L; Gao L; Zhong Y; Wu Y; He J; Zou F; Jian R; Xia S; Chen C; Zhu S BMC Public Health; 2023 Jul; 23(1):1391. PubMed ID: 37468877 [TBL] [Abstract][Full Text] [Related]